PBS Documentary: Shelter Me – Cancer Pioneers
Have you ever wondered about the impact of the invaluable samples contributed by our beloved greyhounds to osteosarcoma research? A groundbreaking documentary, Shelter Me: The Cancer Pioneers, premiered on PBS on May 15th, offering an in-depth look at this vital area of study.
This compelling film features the esteemed Dr. Nicola Mason and the University of Pennsylvania research team, highlighting their pioneering work—some of which is proudly supported by The Greyhound Health Initiative. Their research explores how osteosarcoma in pets can advance treatments for human patients, particularly children, diagnosed with the same devastating disease.
As part of the Emmy Award-winning Shelter Me series, The Cancer Pioneers brings together leading experts from world-renowned institutions, including the National Cancer Institute, the National Institutes of Health, the University of Pennsylvania, the University of Illinois, the University of Wisconsin, and Colorado State University. This documentary delves into the field of comparative oncology, demonstrating how cancer studies in dogs serve as essential models for human therapies and how these findings are shaping the future of cancer treatment. Watch this compelling video.
UPDATE 10/2025: We’re thrilled to share that Shelter Me: The Cancer Pioneers has been nominated for two Daytime Emmy Awards—Outstanding Daytime Special and Outstanding Writing Team!
This powerful documentary highlights the groundbreaking role of dogs in advancing osteosarcoma research for both canine and human patients. GHI’s cancer warriors are helping to drive this life-saving work forward—proving that hope, healing, and discovery can come on four legs.
Dr. Mason will be attending the Daytime Emmys on Friday, October 17th at 7pm ET, proudly representing this groundbreaking research partnership. Join us by streaming live at watch.theemmys.tv and help celebrate the incredible contributions of these courageous dogs and the dedicated scientists working alongside them.
Together, we’re changing the future of cancer care—one hero at a time.
